GGrantIndex
← Search

Optimize Formulation of VSA Adjuvant

$600,000N43FY2022AINIH

Adjuvax Llc, Hoover AL

Investigators

Abstract

The contract supports the development of a saponin as a vaccine adjuvant. The adjuvant development activities are being conducted within the context of vaccines to protect against SARS-CoV-2 and pneumococcal infection.

View original record on NIH RePORTER →
Optimize Formulation of VSA Adjuvant · GrantIndex